DONATE →

Clinical trial 2026-525303-27-00 · Non-small cell lung cancer (NSCLC)

Strongers editorial cover for clinical study 2026-525303-27-00 (Phase II), status: authorised — Non-small cell lung cancer (NSCLC).
Oncology research 16 Nov 2026

2026-525303-27-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Clinical trial 2026-525303-27-00 (phase II) is «authorised» on CTIS (EU Clinical Trials Information System).

Condition: Non-small cell lung cancer (NSCLC) · Registered interventions: ivonescimab, Paclitaxel Teva 6 mg/ml concentrado para solución para perfusión EFG, Carboplatino Teva 10 mg/ml Concentrado para solución para perfusión · Recorded dates (source): 2026-11-12.

Source: https://euclinicaltrials.eu/ctis-public/view/2026-525303-27-00

A newsletter for those who compete, those who donate, those who believe in research

Events, awarded grants, stories of the people who make research possible. One email a month, no spam.